Antibiotic consumption, genetic risk and incidence of metabolic dysfunction-associated steatotic liver disease: a prospective cohort study Ziming Zheng; Yumei Huang; Jijuan Zhang; Jinchi Xie; An Pan; Yunfei Liao; Yu Zhang;

Clinical and molecular implications of antipsychotics in MASLD Celina Gonzalez; Misael Uribe; Norberto C. Chavez-Tapia;

A social media listening study of patients¿ experiences relating to metabolic dysfunction-associated steatotic liver disease: The LISTEN-MASLD study Jeffrey V. Lazarus; William Alazawi; Ron Basuroy; Laurent Castera; Dmitry Estulin; Yiannoula Koulla; Preethy Prasad; Manuel Romero-Gomez; Hirokazu Takahashi; Vincent Wai-Sun Wong; Jörn M. Schattenberg;